However, TBX1 drove activation of the micro-RNA host gene MIR17HG (Figure 5B), which has been reported as key anti-apoptotic target of BCR::ABL1 in CML [42]. This evidence concerns the gene TBX1 and chronic myelogenous leukemia, BCR-ABL1 positive.